Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12156864
Analogs of cyclobenzaprine and amitryptilene
granted -
US 12156879
Combining BACE1 inhibitors with mGluR agonists for Alzheimer's disease therapy
granted -
US 12156863
Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound
granted -
US 12159700
Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
granted -
US 12156893
Oral composition comprising lactic acid bacteria for regulating immune responses and methods related thereto
granted -
US 12156883
Bisphosphocin gel formulations and uses thereof
granted -
US 12157743
Solid forms of Alpha-1062 gluconate
granted -
US 12156870
Antibody drug conjugates comprising sting agonists
granted -
US 12157729
Solid state forms of Belumosudil and Belumosudil salts
granted -
US 12157762
Tethered interleukin-15 and interleukin-21
granted -
US 12156897
Magnesium-containing oxytocin formulations and methods of use
granted -
US 12156940
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 12157778
Peptides for activation of cell signaling in osteoprogenitor cells
granted -
US 12157758
Readily isolated bispecific antibodies with native immunoglobulin format
granted -
US 12157735
Compounds for targeted degradation of BRD9
granted -
US 12156908
Virus like nanoparticle compositions and methods thereof
granted -
US 12156931
Organic counteranion co-assembly strategy for the formation of cyclodextrin-containing hybrid frameworks
granted -
US 12157891
Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitors
granted -
US 12156914
Pharmaceutical compositions comprising bupropion and cysteine
granted -
US 12156912
Methods and compositions for inhibiting diseases of the central nervous system
granted -
US 12156880
Heterocyclic RIP1 kinase inhibitors
granted -
US 12156877
Methods of treating conditions related to a thiamine deficiency, a thiamine-dependent enzyme, or an associated cofactor
granted -
US 12156862
Medicaments for the treatment of vasoconstriction related diseases or disorders
granted -
US 12156903
Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.